Nuclear Medicine on the Internet

Nov 3, 2002

Nuclear medicine comes alive with our newest online interactive textbook, Nuclear Medicine on the Internet, by Scott C. Williams, M.D.

Latest in Nuclear Radiology
Lung Ct Images 400
Pneumonia on CT? Consider additional imaging so as not to miss cancer
December 8, 2023
Chatgpthead
ChatGPT tested on nuclear medicine cases
December 6, 2023
Kidney 400
Telix highlights first patient dosed with new renal cancer PET agent
December 4, 2023
Pet Ct Machine 400
PET/CT predicts patient responses to CAR-T cell therapy
December 4, 2023
More in Nuclear Radiology
Pneumonia on CT? Consider additional imaging so as not to miss cancer
Pneumonia can hide underlying lung cancers, and repeat imaging with PET/CT should be considered in patients with high clinical suspicion of malignancy.
December 8, 2023
Lung Ct Images 400
ChatGPT tested on nuclear medicine cases
ChatGPT shows potential for diagnosing nuclear medicine cases, yet needs further development before it can be implemented in practice.
December 6, 2023
Chatgpthead
Telix highlights first patient dosed with new renal cancer PET agent
Telix Pharmaceuticals is highlighting that the first patient has been dosed with the company's TLX250-CDx for clear cell renal cell carcinoma.
December 4, 2023
Kidney 400
PET/CT predicts patient responses to CAR-T cell therapy
F-18 FDG-PET/CT scans may predict outcomes in patients with large B cell lymphoma undergoing chimeric antigen receptor (CAR) T-cell therapy.
December 4, 2023
Pet Ct Machine 400
Bayer reports results of phase II gadoquatrane clinical trial at RSNA
Bayer presented positive results of its phase II clinical trial of macrocyclic gadolinium-based compound gadoquatraine in a scientific session at RSNA 2023.
November 28, 2023
Bayer Rsna 2019 400
PET tracer shows promise in prostate cancer patients
Gallium-68 RM2-PET/MRI is better than MRI alone for detecting relapse in prostate cancer patients, according to research presented at RSNA 2023.
November 26, 2023
An image showing potentially different sites of PET radiotracer uptake by prostate cancer tumors between U.S. approved Ga-68 PSMA-PET and experimental Ga-68 RM2. Image courtesy of Heying Duan, MD, Stanford University.
FAPI-PET shows promise for detecting pancreatic cancer
FAPI-PET imaging may become a powerful diagnostic tool for detecting pancreatic cancer.
November 20, 2023
A male patient with suspected recurrent pancreatic cancer. Contrast-enhanced CT shows mass around superior mesenteric artery after pancreatectomy. F-18 FDG only shows discrete uptake of lesion (SUVmax, 3.8), whereas Ga-68 FAPI clearly visualizes recurrent tumor. Patient received adjuvant chemotherapy after Ga-68 FAPI. Patient denied recommended chemotherapy. Increase of CA19-9 levels (from 240 U/mL to 767 U/mL) and follow-up imaging eight months later validated progression of mesenteric mass as well as increased F-18 FDG uptake (SUVmax, 5.3). Image courtesy of the Journal of Nuclear Medicine.
AI developed for SPECT kidney imaging in children
An AI model based on SPECT images has the potential to help nuclear medicine physicians identify kidney defects in children, according to a research group in Taiwan.
August 16, 2023
2016 08 23 17 04 30 620 Kidney 400
AI could help evaluate brain tumors on PET
A group in Germany has developed an AI model for PET imaging that could help clinicians determine whether patients are responding to brain tumor treatments, according to a study published August 10 in the Journal of Nuclear Medicine.
August 14, 2023
2023 08 14 20 11 1810 2023 08 14 Pet Ai 400
PET predicts survival in patients with brain tumors
PET imaging can help clinicians predict survival outcomes for patients with brain tumors, according to a study published August 3 in the Journal of Nuclear Medicine.
August 7, 2023
2023 08 07 21 24 1022 2023 08 08 Tspo Pet 20230807213128
New PET radiotracer shows promise in NETs
An experimental PET radiotracer shows promise for detecting metastatic cancer lesions in patients with neuroendocrine tumors, according to a study published July 20 in the Journal of Nuclear Medicine.
July 25, 2023
2023 07 25 22 44 8931 2023 07 25 Pet Nets 20230725225340
SNMMI calls for clarity over Leqembi PET scans
The Society of Nuclear Medicine and Molecular Imagine (SNMMI) has called for clarity over whether amyloid PET scans will be covered for potential candidates for the new Alzheimer's disease drug Leqembi (lecanemab).
July 10, 2023
2021 11 20 00 07 5698 Amyloid Plaque Alzheimer2 400
Page 1 of 78
Next Page